Susan Cannon‐Carlson

1.0k total citations
15 papers, 517 citations indexed

About

Susan Cannon‐Carlson is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Susan Cannon‐Carlson has authored 15 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Immunology. Recurrent topics in Susan Cannon‐Carlson's work include Protein purification and stability (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Virus-based gene therapy research (2 papers). Susan Cannon‐Carlson is often cited by papers focused on Protein purification and stability (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Virus-based gene therapy research (2 papers). Susan Cannon‐Carlson collaborates with scholars based in United States, Netherlands and Switzerland. Susan Cannon‐Carlson's co-authors include John Yew Huat Tang, Marcio Voloch, David Wylie, Collette Cutler, George W. Teebor, Yan‐Hui Liu, Wai Lam W. Ling, Leonard G. Presta, Robert L. Shields and Philip Lipari and has published in prestigious journals such as Journal of Biological Chemistry, Hepatology and Analytical Biochemistry.

In The Last Decade

Susan Cannon‐Carlson

14 papers receiving 478 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan Cannon‐Carlson United States 10 375 108 103 84 80 15 517
Chandtip Chandhasin United States 11 235 0.6× 74 0.7× 130 1.3× 43 0.5× 58 0.7× 22 566
Heike I. Krupka United States 11 332 0.9× 91 0.8× 212 2.1× 112 1.3× 24 0.3× 15 608
Marta Taulés Spain 9 458 1.2× 90 0.8× 91 0.9× 25 0.3× 57 0.7× 13 636
Angelita G. Utleg United States 10 441 1.2× 67 0.6× 76 0.7× 37 0.4× 35 0.4× 10 646
Peter Hilgard Germany 15 286 0.8× 46 0.4× 125 1.2× 36 0.4× 22 0.3× 32 747
Sarai Rodríguez Spain 9 381 1.0× 93 0.9× 205 2.0× 54 0.6× 21 0.3× 11 654
Arnaud Briat France 13 235 0.6× 119 1.1× 128 1.2× 77 0.9× 10 0.1× 23 440
Audrey Baker United States 13 585 1.6× 60 0.6× 181 1.8× 129 1.5× 9 0.1× 21 818
Owen C. Blair United States 12 367 1.0× 61 0.6× 40 0.4× 28 0.3× 19 0.2× 22 521
Justin P. Ludeman Australia 9 265 0.7× 37 0.3× 215 2.1× 69 0.8× 20 0.3× 14 447

Countries citing papers authored by Susan Cannon‐Carlson

Since Specialization
Citations

This map shows the geographic impact of Susan Cannon‐Carlson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Cannon‐Carlson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Cannon‐Carlson more than expected).

Fields of papers citing papers by Susan Cannon‐Carlson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Cannon‐Carlson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Cannon‐Carlson. The network helps show where Susan Cannon‐Carlson may publish in the future.

Co-authorship network of co-authors of Susan Cannon‐Carlson

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Cannon‐Carlson. A scholar is included among the top collaborators of Susan Cannon‐Carlson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Cannon‐Carlson. Susan Cannon‐Carlson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Liu, Yan‐Hui, David Wylie, Jia Zhao, et al.. (2010). Mass spectrometric characterization of the isoforms in Escherichia coli recombinant DNA-derived interferon alpha-2b. Analytical Biochemistry. 408(1). 105–117. 11 indexed citations
3.
Wang, Yan, Denise Williams, Yaolin Wang, et al.. (2005). Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti–IGF-IR antibody. Molecular Cancer Therapeutics. 4(8). 1214–1221. 140 indexed citations
4.
Wylie, David, et al.. (2005). Characterization of Interferon a2B Pegylated via Carboxyalkylation: A Case Study. Humana Press eBooks. 308. 337–348. 4 indexed citations
5.
Machemer, Todd, Heidrun Engler, Van Tsai, et al.. (2005). Characterization of Hemodynamic Events Following Intravascular Infusion of Recombinant Adenovirus Reveals Possible Solutions for Mitigating Cardiovascular Responses. Molecular Therapy. 12(2). 254–263. 13 indexed citations
6.
Grace, Michael J., Sheri Bradshaw, Stuart Cox, et al.. (2005). Site of Pegylation and Polyethylene Glycol Molecule Size Attenuate Interferon-α Antiviral and Antiproliferative Activities through the JAK/STAT Signaling Pathway. Journal of Biological Chemistry. 280(8). 6327–6336. 72 indexed citations
7.
Cannon‐Carlson, Susan, et al.. (2005). CMC and regulatory considerations for polyethylene glycol-modified protein therapeutics. Drug Delivery System. 20(6). 620–634. 2 indexed citations
8.
Ling, Wai Lam W., Liang Deng, Collette Cutler, et al.. (2003). Improvement of Monoclonal Antibody Production in Hybridoma Cells by Dimethyl Sulfoxide. Biotechnology Progress. 19(1). 158–162. 28 indexed citations
9.
Grace, Michael, Susan Cannon‐Carlson, Sheri Bradshaw, et al.. (2003). 1188 Site of pegylation and PEG molecule size directly attenuate interferon-alpha anti-viral specific activity through the JAK/STAT signaling pathway. Hepatology. 38. 729–729. 2 indexed citations
10.
Wylie, David, et al.. (2001). Carboxyalkylated Histidine Is a pH-Dependent Product of Pegylation with SC-PEG. Pharmaceutical Research. 18(9). 1354–1360. 36 indexed citations
11.
Porter, Frederick, Suganto Sutjipto, Collette Cutler, et al.. (2001). Empty Capsids in Column-Purified Recombinant Adenovirus Preparations. Human Gene Therapy. 12(15). 1923–1936. 60 indexed citations
12.
Tsarbopoulos, Anthony, Susan Cannon‐Carlson, David Wylie, et al.. (2000). Mass spectrometric mapping of disulfide bonds in recombinant human interleukin-13. Journal of Mass Spectrometry. 35(3). 446–453. 8 indexed citations
13.
Cannon‐Carlson, Susan, Anthony Tsarbopoulos, Chung‐Her Jenh, et al.. (1998). Expression, Purification, and Characterization of Recombinant Human Interleukin-13 from NS-0 Cells. Protein Expression and Purification. 12(2). 239–248. 9 indexed citations
14.
Cannon‐Carlson, Susan & John Yew Huat Tang. (1997). Modification of the Laemmli Sodium Dodecyl Sulfate–Polyacrylamide Gel Electrophoresis Procedure to Eliminate Artifacts on Reducing and Nonreducing Gels. Analytical Biochemistry. 246(1). 146–148. 60 indexed citations
15.
Cannon‐Carlson, Susan, et al.. (1989). Purification and Characterization of 5-Hydroxymethyluracil-DNA Glycosylase from Calf Thymus. Journal of Biological Chemistry. 264(22). 13306–13312. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026